J. Staub

发表

Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex

R. Tolman, P. Vella, L. Chupak, 1992, Infection and immunity.

Antibody Responses to Capsular Polysaccharide Backbone and O-Acetate Side Groups of Streptococcus pneumoniae Type 9V in Humans and Rhesus Macaques

J. Donnelly, M. Blum, T. McNeely, 1998, Infection and Immunity.

. in Humans and Rhesus Macaques Type 9 V Streptococcus pneumoniae Groups of Polysaccharide Backbone and O-Acetate Side Antibody Responses to Capsular

J. Donnelly, M. Blum, T. McNeely, 1998 .

Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 μg liquid formulation: a comparison of three lots with the 15.0 μg lyophilized formulation

J. Donnelly, G. Overturf, J. Hennessey, 1997 .

Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants.

E. Mulholland, B. Greenwood, J. Todd, 1993, The Pediatric infectious disease journal.

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.

K. Dolan, G. Calandra, H. Matthews, 1990, Pediatrics.

Biological activity of Hib conjugates.

R. Ellis, P. Vella, J. Staub, 1991, Vaccine.

An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.

K. Dolan, R. Ellis, P. Vella, 1991, Journal of immunoassay.

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.

G. Calandra, H. Matthews, R. Ellis, 1990, Pediatrics.